Axiom Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$304K Buy
+10,822
New +$288K 0.23% 77
2022
Q4
$355K Buy
6,924
+2,254
+48% +$108K 0.92% 35
2022
Q3
$206K Sell
4,670
-11,489
-71% -$558K 0.41% 54
2022
Q2
$844K Sell
16,159
-1,785
-10% -$91K 2.43% 9
2022
Q1
$927K Sell
17,944
-1,952
-10% -$101K 2.02% 10
2021
Q4
$1.18M Sell
19,896
-9,535
-32% -$472K 1.14% 19
2021
Q3
$1.27M Sell
29,431
-2,973
-9% -$132K 1.28% 18
2021
Q2
$1.27M Sell
32,404
-1,941
-6% -$75.5K 0.99% 24
2021
Q1
$1.24M Buy
34,345
+33,420
+3,613% +$1.19M 1.01% 20
2020
Q4
$722 Sell
925
-19,922
-96% -$731K 0.66% 39
2020
Q3
$727K Buy
20,847
+13,152
+171% +$461K 0.82% 32
2020
Q2
$241K Buy
7,695
+473
+7% +$16.1K 0.32% 88
2020
Q1
$223K Sell
7,222
-1,159
-14% -$39.5K 0.39% 75
2019
Q4
$313K Sell
8,381
-53,610
-86% -$1.91M 0.45% 70
2019
Q3
$2.12M Sell
61,991
-176,155
-74% -$6.41M 1.62% 12
2019
Q2
$9.77M Sell
238,146
-2,524
-1% -$100K 1.76% 5
2019
Q1
$9.67M Sell
240,670
-1,797
-0.7% -$72K 1.84% 7
2018
Q4
$10M Buy
+242,467
New +$10.1M 2.12% 4

Other funds holding PFE

Axiom Investment Management's PFE Position: Q1 2026 in Review

Axiom Investment Management opened a new position in Pfizer (PFE) in Q1 2026: 10,822 shares worth $304K. The stake represents 0.23% of the portfolio and ranks #77 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in PFE as recently as Q4 2022.

Axiom Investment Management first reported a position in PFE in Q4 2018 and has held it in 18 quarters since. The position peaked at $10M in Q4 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Axiom Investment Management held 10,822 shares of Pfizer worth $304K as of Q1 2026.
  • Pfizer was a new Axiom Investment Management position in Q1 2026.
  • Pfizer made up 0.23% of Axiom Investment Management's portfolio in Q1 2026, its #77 holding.
  • Axiom Investment Management first reported a position in Pfizer in Q4 2018 and has held it in 18 quarters since.
  • Axiom Investment Management's Pfizer position peaked at $10M in Q4 2018.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Axiom Investment Management's 13F filing for Q1 2026, filed 26 May 2026.